ConductScience.org, home

Paper · 4015380

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.

Kalser MH and 1 other. Arch Surg, 1985. Cited by 1,170 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Papers, record 4015380. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4015380

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.
PubMed
Journal
Arch Surg
PubMed
Year
1985
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,170
iCite
Relative citation ratio, by iCite
32.4
iCite
Revised in PubMed
2024-12-19
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kalser MHM H
2Ellenberg SSS S

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Pancreatic NeoplasmsMajor topic
Aged
Combined Modality Therapy
Female
Fluorouracil
Humans
Leukopenia
Male
Middle Aged
Pancreatectomy
Prognosis
Radiotherapy Dosage

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
1-CM-43795NCI NIH HHSUnited StatesN01CM043795PubMed and NIHNIH RePORTER
1-CM-43796NCI NIH HHSUnited StatesN01CM043796PubMed and NIHNIH RePORTER
1-CM-43797NCI NIH HHSUnited StatesN01CM043797PubMed and NIHNIH RePORTER

Trials5

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01553019Postoperative Proton Radiotherapy With Chemo for Pancreatic CancerBackgroundClinicalTrials.gov
NCT02599662Intraoperative Radiation Therapy for Resectable Pancreas CancerBackgroundClinicalTrials.gov
NCT03167112A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic CancerResultsClinicalTrials.gov
NCT03959150Metronomic Chemotherapy With Capecitabine for Pancreatic CancerBackgroundClinicalTrials.gov
NCT04106856Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic CancerBackgroundClinicalTrials.gov

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by415

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,170 citations.

PMIDTitleJournalYearIn PapersSource
42,738,277Adjuvant Therapy in Pancreatic Ductal Adenocarcinoma-Past, Present, and Future.Cancers (Basel)2026https://conductscience.org/library/papers/42738277PubMed
42,592,360Exploring the role of immunotherapy and radiotherapy in the adjuvant landscape of resected pancreatic cancer.Transl Gastroenterol Hepatol2026https://conductscience.org/library/papers/42592360PubMed
42,380,817Comparative efficacy of postoperative adjuvant chemoradiotherapy versus no chemoradiotherapy in the treatment of pancreatic adenocarcinoma.BMC Cancer2026https://conductscience.org/library/papers/42380817PubMed
42,352,447Chemotherapy Completion as a Quality Metric in Resected Pancreatic Ductal Adenocarcinoma.Cancers (Basel)2026https://conductscience.org/library/papers/42352447PubMed
42,169,941Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pancreatic cancer.J Gastrointest Oncol2026https://conductscience.org/library/papers/42169941PubMed
42,129,843Adjuvant stereotactic pancreatic radiotherapy (SPARTA trial): interim safety analysis of an ongoing phase II single center prospective study.Radiat Oncol2026https://conductscience.org/library/papers/42129843PubMed
41,514,607Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making.Cancers (Basel)2025https://conductscience.org/library/papers/41514607PubMed
41,365,129Radiotherapy in the management of PDAC, from past to present.Transl Oncol2026https://conductscience.org/library/papers/41365129PubMed
41,117,833Adjuvant treatment after surgical resection of pancreatic cancer.Surg Today2026https://conductscience.org/library/papers/41117833PubMed
40,662,364Evolving concepts in adjuvant/neoadjuvant therapy for resectable pancreas cancer.J Clin Invest2025https://conductscience.org/library/papers/40662364PubMed

1 to 10 of 415

See all 415 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs4

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
LEUCOVORIN CALCIUMCHEMBL1201138Results1https://conductscience.org/library/drugs/CHEMBL1201138ChEMBL
FLUOROURACILCHEMBL185Results1https://conductscience.org/library/drugs/CHEMBL185ChEMBL
OXALIPLATINCHEMBL414804Results1https://conductscience.org/library/drugs/CHEMBL414804ChEMBL
IRINOTECANCHEMBL481Results1https://conductscience.org/library/drugs/CHEMBL481ChEMBL

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4015380

GET https://conductscience.org/api/papers/v1/4015380/cited_by?page=2